Search Media Items

Learn about the NCI-funded research that enabled the first FDA approved precision medicine- the immune checkpoint inhibitor pembrolizumab.

The results of standard tests indicated that Valerie Winston was at risk for multiple myeloma. Read how an NCI combination therapy clinical trial helped her avoid the full impact of multiple myeloma.

Read how an NCI-funded team led by Robert Vonderheide showed the promise of combining immune checkpoint inhibitors and radiation therapy in melanoma.

Frustration with the toxicities of chemotherapy and radiation spurs cancer survivor and investigator Greg Aune to look for less-toxic therapies for children.

Approximately 70 percent of women diagnosed with ovarian cancer will die from the disease. Read about the NCI-funded combination drug trial that has successfully treated Betsy Brauser's recurrent cancer.

Tobacco use in the US continues to cause great harm. Learn about Dr. Michael Fiore and his NCI working group’s recommendations on Tobacco Control Research Priorities for the Next Decade.

Learn how Sue Wharfe benefitted from taking part in a clinical trial of exercise and nutrition for breast cancer survivors that was supported by NCI funding.

Read about how NCI is working to reduce cancer disparities by bringing clinical trials to minority and underserved communities.

About a third of all cancers are driven by mutations in RAS genes. Learn how NCI funding is helping Dr. Kevan Shokat develop drugs that inactivate molecular drivers of cancer such as RAS.

Learn how NCI support is helping researcher David Lyden understand how cancer cell exosomes create a nurturing environment for the growth of metastatic tumors.